
Two fen drugs selling by American Home Products Pondimin and Redux or 
dexfenfluramine . . . Much of early 1990s, American Home Products greatly 
underreporting associations of Pondimin with primary pulmonary hypertension to get 
FDA approval of Redux in 1996 . . . Smith taking drug fenfluramine, brand naming 
Pondimin and phentermine for about year and lost 70 pounds . . . Plaintiffs' lawyers 
saying that American Home wants to avoid jury decision when trying to negotiate 
settlement of fen-phen litigation . . . 1996 European study saying long-term users of 
prescription diet drugs having 23-fold greater risk than general public of incurring 
primary pulmonary hypertension . . . Fen-phen cases alleging heart-valve leakage 
problems having various symptoms . . . Lawyers familiar with litigation over diet drugs 
saying several fen-phen death cases in country settling for about $4 million to $5 million 
each . . . 23 to 46 per million users and no widely accepted biological mechanism linking 
drugs to disease . . . No jury deliberating on fen-phen case and Smith case furthest . . . 
Plaintiffs' attorneys tried to show company seeking to avoid serious type of warning label 
because drastically cutting sales . . . 

